Role of PCSK9 (proprotein convertase subtilisin/kexin type 9) in obesity and metabolic syndrome: Beyond LDLR targeting

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 252; p. e223
Main Authors Balzarotti, G, Tibolla, G, Ruscica, M, Stramba-Badiale, M, Catapano, A.L, Norata, D.G
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2016
Subjects
Cardiovascular
Online AccessGet full text

Cover

More Information
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2016.07.191